These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26631313)

  • 1. Design and optimization of selective azaindole amide M1 positive allosteric modulators.
    Davoren JE; O'Neil SV; Anderson DP; Brodney MA; Chenard L; Dlugolenski K; Edgerton JR; Green M; Garnsey M; Grimwood S; Harris AR; Kauffman GW; LaChapelle E; Lazzaro JT; Lee CW; Lotarski SM; Nason DM; Obach RS; Reinhart V; Salomon-Ferrer R; Steyn SJ; Webb D; Yan J; Zhang L
    Bioorg Med Chem Lett; 2016 Jan; 26(2):650-655. PubMed ID: 26631313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M(1) positive allosteric modulators.
    Kuduk SD; Di Marco CN; Saffold JR; Ray WJ; Ma L; Wittmann M; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Beshore DC
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1417-20. PubMed ID: 24485781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects.
    Davoren JE; Lee CW; Garnsey M; Brodney MA; Cordes J; Dlugolenski K; Edgerton JR; Harris AR; Helal CJ; Jenkinson S; Kauffman GW; Kenakin TP; Lazzaro JT; Lotarski SM; Mao Y; Nason DM; Northcott C; Nottebaum L; O'Neil SV; Pettersen B; Popiolek M; Reinhart V; Salomon-Ferrer R; Steyn SJ; Webb D; Zhang L; Grimwood S
    J Med Chem; 2016 Jul; 59(13):6313-28. PubMed ID: 27275946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse Effects on M
    Rook JM; Abe M; Cho HP; Nance KD; Luscombe VB; Adams JJ; Dickerson JW; Remke DH; Garcia-Barrantes PM; Engers DW; Engers JL; Chang S; Foster JJ; Blobaum AL; Niswender CM; Jones CK; Conn PJ; Lindsley CW
    ACS Chem Neurosci; 2017 Apr; 8(4):866-883. PubMed ID: 28001356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): the development of ML169, an MLPCN probe.
    Reid PR; Bridges TM; Sheffler DJ; Cho HP; Lewis LM; Days E; Daniels JS; Jones CK; Niswender CM; Weaver CD; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2011 May; 21(9):2697-701. PubMed ID: 21194936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M
    Engers JL; Bender AM; Kalbfleisch JJ; Cho HP; Lingenfelter KS; Luscombe VB; Han C; Melancon BJ; Blobaum AL; Dickerson JW; Rook JM; Niswender CM; Emmitte KA; Conn PJ; Lindsley CW
    ACS Chem Neurosci; 2019 Mar; 10(3):1035-1042. PubMed ID: 30086237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Approach to Discovering Novel Muscarinic M
    Kurimoto E; Matsuda S; Shimizu Y; Sako Y; Mandai T; Sugimoto T; Sakamoto H; Kimura H
    J Pharmacol Exp Ther; 2018 Jan; 364(1):28-37. PubMed ID: 29025977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.
    Budzik B; Garzya V; Shi D; Walker G; Lauchart Y; Lucas AJ; Rivero RA; Langmead CJ; Watson J; Wu Z; Forbes IT; Jin J
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3545-9. PubMed ID: 20483599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M₁ agonists.
    Liu B; Croy CH; Hitchcock SA; Allen JR; Rao Z; Evans D; Bures MG; McKinzie DL; Watt ML; Stuart Gregory G; Hansen MM; Hoogestraat PJ; Jamison JA; Okha-Mokube FM; Stratford RE; Turner W; Bymaster F; Felder CC
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4158-63. PubMed ID: 26299349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor.
    Mistry SN; Lim H; Jörg M; Capuano B; Christopoulos A; Lane JR; Scammells PJ
    ACS Chem Neurosci; 2016 May; 7(5):647-61. PubMed ID: 26891194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The existence of a second allosteric site on the M1 muscarinic acetylcholine receptor and its implications for drug design.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1217-20. PubMed ID: 16364641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of TAK-071, a muscarinic M
    Kurimoto E; Yamada R; Hirakawa T; Kimura H
    Neurosci Lett; 2021 Nov; 764():136240. PubMed ID: 34509568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.
    Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in the development of an M
    Tarr JC; Wood MR; Noetzel MJ; Bertron JL; Weiner RL; Rodriguez AL; Lamsal A; Byers FW; Chang S; Cho HP; Jones CK; Niswender CM; Wood MW; Brandon NJ; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2990-2995. PubMed ID: 28522253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M
    Spearing PK; Cho HP; Luscombe VB; Blobaum AL; Boutaud O; Engers DW; Rodriguez AL; Niswender CM; Jeffrey Conn P; Lindsley CW; Bender AM
    Bioorg Med Chem Lett; 2021 Sep; 47():128193. PubMed ID: 34118412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs).
    Kuduk SD; Beshore DC
    Curr Top Med Chem; 2014; 14(15):1738-54. PubMed ID: 25176125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.
    Bridges TM; Kennedy JP; Cho HP; Breininger ML; Gentry PR; Hopkins CR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Jan; 20(2):558-62. PubMed ID: 20004578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration.
    Panarese JD; Cho HP; Adams JJ; Nance KD; Garcia-Barrantes PM; Chang S; Morrison RD; Blobaum AL; Niswender CM; Stauffer SR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3822-5. PubMed ID: 27173801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel M
    Poslusney MS; Salovich JM; Wood MR; Melancon BJ; Bollinger KA; Luscombe VB; Rodriguez AL; Engers DW; Bridges TM; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2019 Feb; 29(3):362-366. PubMed ID: 30580918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulators.
    Han C; Chatterjee A; Noetzel MJ; Panarese JD; Smith E; Chase P; Hodder P; Niswender C; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Jan; 25(2):384-8. PubMed ID: 25435150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.